These data highlight two critical points: (1) ESR1 expression was lower in gliomas compared to healthy tissue, (2) but also was higher in GBM compared to LGG, suggesting an important oncogenic role of ER-α in development of low- and high-grade gliomas. Here, ESR1 is linked to central nervous system cancer.